| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Howard V Oconnell last filed a Form 4 in February 2015, as Director at TECH. Howard V Oconnell's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 70,000 shares of TECH. The TECH filings lean toward selling, a net 5,000 shares.
Howard V Oconnell has 1 Form 4 filing on record in February 2015, as Director at Bio-Techne (TECH), 2015.
The 2 reported transactions were 1 option exercise and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $479K.
The only open-market sale was 5,000 shares of TECH at an average $95.78 on February 19, 2015, about $479K.
Shares as reported in the last Form 4 for each company; the most recent is from February 2015. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2015 | TECH Bio-Techne Corp | Director | Sale+OE | 5,000 | $95.78 | $478,882.00 | -6.7% |